Literature DB >> 3292666

Fibronectin-cleaving activity in bronchial secretions of patients with cystic fibrosis.

S Suter1, U B Schaad, J J Morgenthaler, I Chevallier, H P Schnebli.   

Abstract

In cystic fibrosis, colonization of the airways with Pseudomonas aeruginosa follows colonization with Staphylococcus aureus and is related to accelerated deterioration of pulmonary function. Because P. aeruginosa adheres better to cell surfaces devoid of fibronectin, we searched for fibronectin-cleaving activity in bronchial secretions and saliva from 24 patients with cystic fibrosis who were followed up for 4.5 y and from two control groups. Proteolytic activity against 125I-labeled fibronectin was continuously present in cystic fibrosis bronchial secretions; significantly higher fibronectin-cleaving activity was found in older vs. younger patients, in patients with advanced disease stages determined by a five-stage scoring system, and in those colonized with P. aeruginosa. The fibronectin-cleaving activity was due to neutrophil elastase and cathepsin G. Cystic fibrosis bronchial secretions had proteolytic activity against surface fibronectin of airway mucosal cells. Thus fibronectin-cleaving activity of bronchial secretions rather than of saliva may favor P. aeruginosa colonization of the upper respiratory tract in individuals with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292666     DOI: 10.1093/infdis/158.1.89

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Cystic fibrosis, pathophysiological and clinical aspects.

Authors:  H J Neijens; M Sinaasappel; R de Groot; J C de Jongste; S E Overbeek
Journal:  Eur J Pediatr       Date:  1990-08       Impact factor: 3.183

Review 2.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

3.  Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease.

Authors:  R Mahadeva; S Stewart; D Bilton; D A Lomas
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

4.  Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.

Authors:  M F Tosi; H Zakem; M Berger
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin.

Authors:  U B Schaad; J Wedgwood-Krucko; K Guenin; U Buehlmann; R Kraemer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

Review 6.  New perspectives in understanding and management of the respiratory disease in cystic fibrosis.

Authors:  S Suter
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

Review 7.  The protease-antiprotease battle in the cystic fibrosis lung.

Authors:  I M Balfour-Lynn
Journal:  J R Soc Med       Date:  1999       Impact factor: 18.000

8.  Streptococcus pneumoniae disrupts pulmonary immune defence via elastase release following pneumolysin-dependent neutrophil lysis.

Authors:  Hisanori Domon; Masataka Oda; Tomoki Maekawa; Kosuke Nagai; Wataru Takeda; Yutaka Terao
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.